Article Sidebar

pdf
Date Published: 02/12/2024
Abstract Views: 139
Views pdf: 74
DOI: https://doi.org/10.51298/vmj.v544i3.12040
Issue
Vol. 544 No. 3 (2024)
Section
Các bài báo
How to Cite
Lê, Q. H., Nguyễn, T. T. N., Trần, T. T., Trương, Q. T., & Đặng, T. T. K. (2024). TREATMENT COSTS FOR COVID-19 PATIENTS AT CHO RAY HOSPITAL IN HO CHI MINH CITY: A RETROSPECTIVE SURVEY. Vietnam Medical Journal, 544(3). https://doi.org/10.51298/vmj.v544i3.12040

TREATMENT COSTS FOR COVID-19 PATIENTS AT CHO RAY HOSPITAL IN HO CHI MINH CITY: A RETROSPECTIVE SURVEY

Quốc Hùng Lê, Thị Thủy Ngân Nguyễn, Thị Thúy Trần, Quang Tiến Trương, Thị Thúy Kiều Đặng

Main Article Content

Abstract

Objective: This study aimed to investigate the average treatment costs for COVID-19 patients at varying levels of severity at Cho Ray Hospital, Ho Chi Minh City. Methods: A retrospective, cross-sectional study was conducted on 351 COVID-19 inpatients treated at Cho Ray Hospital from August to October 2021. The average treatment costs were calculated based on the severity of the disease, and key factors influencing treatment costs were analyzed. Results: The average treatment cost for a COVID-19 patient was 55 million VND. The critically ill and severe patients had an average treatment cost over five times higher than the moderate group (142.7 million VND compared to 27.4 million VND). Factors affecting the costs included disease severity, length of hospital stay, time spent in the intensive care unit, and treatment interventions such as mechanical ventilation and dialysis. Conclusion: The treatment costs for COVID-19 patients are extremely high, especially for those in severe and critical conditions. Preventing disease progression and optimizing treatment management may help reduce the financial burden.

Article Details

Keywords

treatment costs, hospital fees, Coronavirus, COVID-19, SARS-CoV-2, Vietnam

References

1. Al Mutair, A., Layqah, L., Alhassan, B., Alkhalifah, S., Almossabeh, M., AlSaleh, T.,... Rabaan, A. A. Estimated cost of treating hospitalized COVID-19 patients in Saudi Arabia. Sci Rep, 12(1), 21487. 2022. doi:10.1038/s41598-022-26042-z.
2. Castillo RM, C. V., Panelo CI, Jimeno C. E. E386 Cost-of-Illness Analysis of Coronavirus Disease 2019 (COVID-19) Treatment in the Philippine General Hospital. Value Health, 25(7): S410–1. 2022. doi:10.1016/j.jval.2022. 04.634.
3. Collaborators, C.-E. M. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet, 399(10334), 1513-1536. 2022. doi:10.1016/S0140-6736(21)02796-3.
4. Izadi, R., Hatam, N., Baberi, F., Yousefzadeh, S., & Jafari, A. Economic evaluation of strategies against coronavirus: a systematic review. Health Econ Rev, 13(1), 18. 2023. doi:10.1186/s13561-023-00430-1.
5. Kapinos, K. A., Peters, R. M., Jr., Murphy, R. E., Hohmann, S. F., Podichetty, A., & Greenberg, R. S. Inpatient Costs of Treating Patients With COVID-19. JAMA Netw Open, 7(1), e2350145. 2024. doi:10.1001/jamanetworkopen. 2023.50145.
6. WHO. WHO COVID-19 dashboard. 2022. Retrieved from https://data.who.int/dashboards/ covid19/cases
7. Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Reimbaeva, M.,... Nguyen, J. L. Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study. BMJ Open, 13(12), e075495. 2023. doi:10.1136/bmjopen-2023-075495.
8. Yuan, S., Li, T., Chu, C., Wang, X., & Liu, L. Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions. Front Public Health, 11, 1066694. 2023. doi:10.3389/fpubh.2023. 1066694.